We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Estee Lauder's New Skin Science Strategy Fuel Long-Term Growth?
Read MoreHide Full Article
Key Takeaways
Estee Lauder launched Mastering Skin Longevity to accelerate innovation in aging and long-term skin health.
The platform builds on over 20 years of research and unites five brands to advance differentiated skin care.
Estee Lauder's new platform could boost consumer engagement and support long-term growth through innovation.
The Estee Lauder Companies Inc. (EL - Free Report) is strengthening scientific innovation capabilities to address growing consumer demand for advanced skin care solutions focused on aging and long-term skin health. The company has introduced Mastering Skin Longevity, a new scientific innovation platform designed to accelerate product development and expand opportunities across the premium beauty market. The initiative reflects a growing focus on research-driven products that address evolving consumer preferences.
Unveiled at the China International Import Expo in Shanghai, the platform focuses on Master Regulators of Skin Longevity, biological pathways and proteins that influence several aspects of skin aging. Unlike traditional research targeting individual signs of aging, the approach examines interconnected biological processes responsible for skin repair, resilience and regeneration. Key research areas include sirtuins, which support cellular repair; AMPK, which regulates cellular energy and mTOR, which influences cellular renewal.
This initiative builds on more than two decades of longevity research, including advances in epigenetics, biological aging and cellular repair. Research facilities in Melville and Shanghai will support discoveries across ingredients, formulations and technologies. The platform also brings together brands including Estee Lauder, La Mer, Clinique, Lab Series and The Ordinary, allowing each brand to pursue differentiated skin care innovations. Supporting the launch, Estee Lauder introduced the Skin Longevity Clock, a scientific white paper incorporating international research perspectives, and the EsteeLab Longevity Mirror, an interactive consumer experience.
The latest initiative complements Estee Lauder's broader innovation strategy and recent recovery in skin care. In first-quarter fiscal 2027, organic skin care sales increased 4%, supported by La Mer and The Ordinary. Mainland China delivered 9% organic sales growth, highlighting encouraging demand in a key market for premium beauty products.
Looking ahead, Estee Lauder expects fiscal 2027 organic sales growth of 4% to 5.5%, with adjusted operating margins projected at 12.9% to 13.7%. Continued scientific innovation and differentiated product offerings could strengthen consumer engagement and support longer-term growth, although commercial benefits from the new platform remain to be seen.
Shares of this Zacks Rank #2 (Buy) company have gained 13.4% in the past month compared with the broader Consumer Staples sector and the industry’s growth of 6% and 14.4%, respectively. EL has also outperformed the S&P 500 index’s decline of 4.1% during the same period.
EL Stock's Past Month Performance
Image Source: Zacks Investment Research
Is Estee Lauder a Value Play Stock?
EL currently trades at a forward 12-month P/E ratio of 31.01 compared with the industry average of 26.71. This valuation places the stock at a premium relative to peers, indicating broader market expectations around its business stability and ability to navigate current cost and demand dynamics.
The Zacks Consensus Estimate for e.l.f. Beauty’s current fiscal-year sales and earnings calls for growth of 24% and 18.9%, respectively, from the year-ago reported numbers. ELF delivered a trailing four-quarter earnings surprise of 80.5%, on average.
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) is a leading membership-based warehouse club operator concentrated primarily in the eastern half of the United States. It currently has a Zacks Rank #2. BJ’s Wholesale delivered a trailing four-quarter earnings surprise of 4.8%, on average.
The Zacks Consensus Estimate for BJ’s current fiscal-year sales and EPS indicates growth of 11.7% and 6.8%, respectively, from the prior-year reported levels.
The J. M. Smucker Company (SJM - Free Report) manufactures and markets branded food and beverage products worldwide. It currently carries a Zacks Rank #2. SJM delivered a trailing four-quarter earnings surprise of 13.8%, on average.
The Zacks Consensus Estimate for The J. M. Smucker’s current fiscal-year earnings indicates growth of 17.1% from the prior-year reported levels.
View the Zacks #1 Rank List
Image: Bigstock
Can Estee Lauder's New Skin Science Strategy Fuel Long-Term Growth?
Key Takeaways
The Estee Lauder Companies Inc. (EL - Free Report) is strengthening scientific innovation capabilities to address growing consumer demand for advanced skin care solutions focused on aging and long-term skin health. The company has introduced Mastering Skin Longevity, a new scientific innovation platform designed to accelerate product development and expand opportunities across the premium beauty market. The initiative reflects a growing focus on research-driven products that address evolving consumer preferences.
Unveiled at the China International Import Expo in Shanghai, the platform focuses on Master Regulators of Skin Longevity, biological pathways and proteins that influence several aspects of skin aging. Unlike traditional research targeting individual signs of aging, the approach examines interconnected biological processes responsible for skin repair, resilience and regeneration. Key research areas include sirtuins, which support cellular repair; AMPK, which regulates cellular energy and mTOR, which influences cellular renewal.
This initiative builds on more than two decades of longevity research, including advances in epigenetics, biological aging and cellular repair. Research facilities in Melville and Shanghai will support discoveries across ingredients, formulations and technologies. The platform also brings together brands including Estee Lauder, La Mer, Clinique, Lab Series and The Ordinary, allowing each brand to pursue differentiated skin care innovations. Supporting the launch, Estee Lauder introduced the Skin Longevity Clock, a scientific white paper incorporating international research perspectives, and the EsteeLab Longevity Mirror, an interactive consumer experience.
The latest initiative complements Estee Lauder's broader innovation strategy and recent recovery in skin care. In first-quarter fiscal 2027, organic skin care sales increased 4%, supported by La Mer and The Ordinary. Mainland China delivered 9% organic sales growth, highlighting encouraging demand in a key market for premium beauty products.
Looking ahead, Estee Lauder expects fiscal 2027 organic sales growth of 4% to 5.5%, with adjusted operating margins projected at 12.9% to 13.7%. Continued scientific innovation and differentiated product offerings could strengthen consumer engagement and support longer-term growth, although commercial benefits from the new platform remain to be seen.
Estee Lauder’s Zacks Rank & Share Price Performance
Shares of this Zacks Rank #2 (Buy) company have gained 13.4% in the past month compared with the broader Consumer Staples sector and the industry’s growth of 6% and 14.4%, respectively. EL has also outperformed the S&P 500 index’s decline of 4.1% during the same period.
EL Stock's Past Month Performance
Image Source: Zacks Investment Research
Is Estee Lauder a Value Play Stock?
EL currently trades at a forward 12-month P/E ratio of 31.01 compared with the industry average of 26.71. This valuation places the stock at a premium relative to peers, indicating broader market expectations around its business stability and ability to navigate current cost and demand dynamics.
EL P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Other Stocks to Consider
e.l.f. Beauty, Inc. (ELF - Free Report) provides cosmetics and skin care products worldwide and currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for e.l.f. Beauty’s current fiscal-year sales and earnings calls for growth of 24% and 18.9%, respectively, from the year-ago reported numbers. ELF delivered a trailing four-quarter earnings surprise of 80.5%, on average.
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) is a leading membership-based warehouse club operator concentrated primarily in the eastern half of the United States. It currently has a Zacks Rank #2. BJ’s Wholesale delivered a trailing four-quarter earnings surprise of 4.8%, on average.
The Zacks Consensus Estimate for BJ’s current fiscal-year sales and EPS indicates growth of 11.7% and 6.8%, respectively, from the prior-year reported levels.
The J. M. Smucker Company (SJM - Free Report) manufactures and markets branded food and beverage products worldwide. It currently carries a Zacks Rank #2. SJM delivered a trailing four-quarter earnings surprise of 13.8%, on average.
The Zacks Consensus Estimate for The J. M. Smucker’s current fiscal-year earnings indicates growth of 17.1% from the prior-year reported levels.